No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Porton Pharma Solutions Ltd. caters to pharmaceutical companies by manufacturing and supplying a diverse portfolio of products, which encompasses small molecule active pharmaceutical ingredients (APIs), drug intermediates, various dosage forms, and biologics. The company was formerly known as Porton Fine Chemicals Ltd. until it adopted its current name in January 2018. Established in 2005, Porton Pharma Solutions Ltd. operates from its headquarters in Chongqing, China.
www.portonpharma.comNo one on the platform currently holds 300363.SZ.
No tracked institution reports a position in 300363.SZ as of their last filing.
No one on the platform has traded 300363.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.3% | — | — | — | ||
| Rev. Growth % | 13.0% | 10.4% | ||||
| Profit Margin % | 2.8% | 9.2% | 10.6% | |||
| Free Cash Flow Margin % | 14.0% | 1.5% | 4.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.9B | +12.9% | $-0.15 | $-0.15–$-0.15 | — | 1 |
| 2027 | $4.4B | +12.8% | $0.58 | $0.58–$0.58 | — | 1 |
| 2028 | $4.9B | +10.4% | $0.85 | $0.85–$0.85 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300363.SZPorton Pharma Solutions Ltd. | $22.06 | +3.96% | $12.0B | — |
| 002287.SZTibet Cheezheng Tibetan Medicine Co., Ltd. | $19.21 | +0.58% | $11.0B | — |
| 300181.SZZhejiang Jolly Pharmaceutical Co.,LTD | $13.18 | +0.15% | $9.1B | — |
| 300294.SZChina Resources Boya Bio-pharmaceutical Group Co., Ltd. | $14.00 | +0.43% | $7.1B | — |
| 301015.SZQingdao Baheal Medical Inc. | $22.92 | -2.51% | $12.0B | — |
| 301207.SZHualan Biological Bacterin Inc. | $18.13 | +1.28% | $10.8B | — |
| 600201.SSJinyu Bio-technology Co., Ltd. | $11.61 | -0.68% | $12.9B | — |
Source: Financial Modeling Prep · peers by sector/industry